At a Glance
| Alpha-GPC | 5-Hydroxytryptophan | |
|---|---|---|
| Class | Nootropic | Nootropic |
| Common Dose (oral) | 300–500 mg | 100–300 mg |
| Total Duration | 0.8–1.3 hrs | — |
| Routes | oral | oral |
| Effects | 11 documented | 5 documented |
Alpha-GPC, a Nootropic, and 5-Hydroxytryptophan, a Nootropic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Nootropics, meaning they share a common pharmacological foundation. They share 1 documented effects in common, with 10 effects unique to Alpha-GPC and 4 unique to 5-Hydroxytryptophan. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Alpha-GPC | 5-Hydroxytryptophan | |
|---|---|---|
| Class | Nootropic | Nootropic |
| Common Dose (oral) | 300–500 mg | 100–300 mg |
| Total Duration | 0.8–1.3 hrs | — |
| Routes | oral | oral |
| Effects | 11 documented | 5 documented |
| Level | Alpha-GPC | 5-Hydroxytryptophan |
|---|---|---|
| Threshold | 50 mg | 25 mg |
| Light | 100–300 mg | 50–100 mg |
| Common | 300–500 mg | 100–300 mg |
| Strong | 500–1000 mg | 300–500 mg |
| Heavy | 1000 mg | 500 mg |
Alpha-GPC
Total: 4 hrs – 8 hrs
5-Hydroxytryptophan
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.